Oxandrolone
SIGMA/SML0437 - ≥98% (HPLC)
Synonym: 17β-Hydroxy-17α-methyl-2-oxa-5α-androstan-3-one; 8075CB; NSC 67068; Oxandren; Provitar; SC 11585; Vasorome
CAS Number: 53-39-4
Empirical Formula (Hill Notation): C19H30O3
Molecular Weight: 306.44
EC Number: 200-172-9
MDL Number: MFCD00198944
Linear Formula: C19H30O3
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
drug control | USDEA Schedule IIIN; regulated under CDSA - not available from Sigma-Aldrich Canada |
form | powder |
InChI | 1S/C19H30O3/c1-17-11-22-1 |
InChI key | QSLJIVKCVHQPLV-PEMPUTJUSA |
optical activity | [α]/D -19 to -26°, c = 1 (CDCl3) |
Quality Level | 100 ![]() |
SMILES string | C[C@]1(O)CC[C@H]2[C@@H]3C |
solubility | DMSO: 2 mg/mL (clear solution; warmed) |
storage temp. | 2-8°C |
Biochem/physiol Actions: | Oxandrolone is a synthetic anabolic steroid. It is is a non-aromatizable androgen with no estrogenic effects and with mild androgenic activity. Clinical uses of oxandrolone include to promote weight gain after weight loss following extensive surgery or chronic infections or trauma, to offset the protein catabolism associated with prolonged administration of corticosteroids, to relieve bone pain frequently accompanying osteoporosis, and to treat Turner′s syndrome in girls. |
Features and Benefits: | This compound is featured on the Nuclear Receptors (Steroids) ![]() ![]() |
Symbol | ![]() |
Signal word | Danger |
Hazard statements | H351 - H360FD |
Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
Hazard Codes | T |
Risk Statements | 60-63-20/21/22 |
Safety Statements | 22-36/37/39-45 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 51111800 |